Cargando…
Pagano L, Salmanton-García J, Marchesi F, et al. Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey. Blood. 2022;140(26):2773-2787.
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10268901/ https://www.ncbi.nlm.nih.gov/pubmed/37318902 http://dx.doi.org/10.1182/blood.2023020789 |
_version_ | 1785059138378661888 |
---|---|
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10268901 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | The American Society of Hematology |
record_format | MEDLINE/PubMed |
spelling | pubmed-102689012023-06-15 Pagano L, Salmanton-García J, Marchesi F, et al. Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey. Blood. 2022;140(26):2773-2787. Blood Erratum The American Society of Hematology 2023-06-15 2023-06-15 /pmc/articles/PMC10268901/ /pubmed/37318902 http://dx.doi.org/10.1182/blood.2023020789 Text en © 2023 by The American Society of Hematology. |
spellingShingle | Erratum Pagano L, Salmanton-García J, Marchesi F, et al. Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey. Blood. 2022;140(26):2773-2787. |
title | Pagano L, Salmanton-García J, Marchesi F, et al. Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey. Blood. 2022;140(26):2773-2787. |
title_full | Pagano L, Salmanton-García J, Marchesi F, et al. Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey. Blood. 2022;140(26):2773-2787. |
title_fullStr | Pagano L, Salmanton-García J, Marchesi F, et al. Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey. Blood. 2022;140(26):2773-2787. |
title_full_unstemmed | Pagano L, Salmanton-García J, Marchesi F, et al. Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey. Blood. 2022;140(26):2773-2787. |
title_short | Pagano L, Salmanton-García J, Marchesi F, et al. Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey. Blood. 2022;140(26):2773-2787. |
title_sort | pagano l, salmanton-garcía j, marchesi f, et al. breakthrough covid-19 in vaccinated patients with hematologic malignancies: results from the epicovideha survey. blood. 2022;140(26):2773-2787. |
topic | Erratum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10268901/ https://www.ncbi.nlm.nih.gov/pubmed/37318902 http://dx.doi.org/10.1182/blood.2023020789 |